Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State

NCT01338623 is registered in ClinicalTrials.gov with Biocinese as lead sponsor.

NCT NCT01338623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01338623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence Study of Tansulosine 0,4 mg Capsule in Health Subjects -Fed State
Lead sponsor
Biocinese
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2011
Completion date
May 31, 2011
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperplasia prostatic